These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24925722)

  • 41. Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without Albuminuria.
    Vistisen D; Andersen GS; Hulman A; Persson F; Rossing P; Jørgensen ME
    Diabetes Care; 2019 Oct; 42(10):1886-1894. PubMed ID: 31221677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased risk of renal deterioration associated with low e-GFR in type 2 diabetes mellitus only in albuminuric subjects.
    Meguro S; Shigihara T; Kabeya Y; Tomita M; Atsumi Y
    Intern Med; 2009; 48(9):657-63. PubMed ID: 19420810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data.
    Afkarian M; Polsky S; Parsa A; Aronson R; Caramori ML; Cherney DZ; Crandall JP; de Boer IH; Elliott TG; Galecki AT; Goldfine AB; Haw JS; Hirsch IB; Karger AB; Lingvay I; Maahs DM; McGill JB; Molitch ME; Perkins BA; Pop-Busui R; Pragnell M; Rosas SE; Rossing P; Senior P; Sigal RJ; Spino C; Tuttle KR; Umpierrez GE; Wallia A; Weinstock RS; Wu C; Mauer M; Doria A;
    Diabetes Care; 2019 Aug; 42(8):1454-1463. PubMed ID: 31186299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protein intake is not associated with progression of diabetic kidney disease in patients without macroalbuminuria.
    Kaji A; Hashimoto Y; Kobayashi Y; Wada S; Kuwahata M; Yamazaki M; Fukui M
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3150. PubMed ID: 30860658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study.
    Giorgino F; Laviola L; Cavallo Perin P; Solnica B; Fuller J; Chaturvedi N
    Diabetologia; 2004 Jun; 47(6):1020-8. PubMed ID: 15170497
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Depression Is Associated With Progression of Diabetic Nephropathy in Type 1 Diabetes.
    Ahola AJ; Harjutsalo V; Forsblom C; Pouwer F; Groop PH;
    Diabetes Care; 2021 Jan; 44(1):174-180. PubMed ID: 33177173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.
    Fufaa GD; Weil EJ; Lemley KV; Knowler WC; Brosius FC; Yee B; Mauer M; Nelson RG
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):254-61. PubMed ID: 26792530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients.
    Steinke JM; Sinaiko AR; Kramer MS; Suissa S; Chavers BM; Mauer M;
    Diabetes; 2005 Jul; 54(7):2164-71. PubMed ID: 15983218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy.
    Panduru NM; Saraheimo M; Forsblom C; Thorn LM; Gordin D; Wadén J; Tolonen N; Bierhaus A; Humpert PM; Groop PH;
    Diabetes Care; 2015 May; 38(5):883-90. PubMed ID: 25720601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimal Frequency of Urinary Albumin Screening in Type 1 Diabetes.
    Perkins BA; Bebu I; de Boer IH; Molitch M; Zinman B; Bantle J; Lorenzi GM; Nathan DM; Lachin JM
    Diabetes Care; 2022 Dec; 45(12):2943-2949. PubMed ID: 36321737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis.
    Costacou T; Fried L; Ellis D; Orchard TJ
    Am J Kidney Dis; 2011 Oct; 58(4):565-73. PubMed ID: 21840097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening.
    Halbesma N; Kuiken DS; Brantsma AH; Bakker SJ; Wetzels JF; De Zeeuw D; De Jong PE; Gansevoort RT
    J Am Soc Nephrol; 2006 Sep; 17(9):2582-90. PubMed ID: 16899519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.
    Forsblom C; Harjutsalo V; Thorn LM; Wadén J; Tolonen N; Saraheimo M; Gordin D; Moran JL; Thomas MC; Groop PH;
    J Am Soc Nephrol; 2011 Mar; 22(3):537-44. PubMed ID: 21335512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impaired Glomerular Filtration Rate in Type 2 Diabetes Mellitus Subjects: A Nationwide Cross-Sectional Study in Thailand.
    Nata N; Rangsin R; Supasyndh O; Satirapoj B
    J Diabetes Res; 2020; 2020():6353949. PubMed ID: 32855974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes.
    Orlov S; Cherney DZ; Pop-Busui R; Lovblom LE; Ficociello LH; Smiles AM; Warram JH; Krolewski AS; Perkins BA
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1136-44. PubMed ID: 26092828
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial.
    Joergensen C; Tarnow L; Goetze JP; Rossing P
    Diabet Med; 2015 Mar; 32(3):374-81. PubMed ID: 25307511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of low-dose acetylsalicylic acid on kidney function in type 2 diabetic patients with elevated urinary albumin excretion rate.
    Gaede P; Hansen HP; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2003 Mar; 18(3):539-42. PubMed ID: 12584276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.
    Kramer HJ; Nguyen QD; Curhan G; Hsu CY
    JAMA; 2003 Jun; 289(24):3273-7. PubMed ID: 12824208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smoking and progression of diabetic nephropathy in type 1 diabetes.
    Hovind P; Rossing P; Tarnow L; Parving HH
    Diabetes Care; 2003 Mar; 26(3):911-6. PubMed ID: 12610058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.